American Society for Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics (2005) 79, P29–P29; doi: 10.1016/j.clpt.2005.12.108
OIII-A-3
Lengthening of cardiac repolarization during the sequential administration of two IKR blockers: Order of administration as a major determinant
R. Hreiche PharmD, MSc1 and J. Turgeon PhD1
1Universiteé de Montreéal, Montreal, PQM, Canada
Abstract
Background/aims: Block of IKrcauses significant lengthening of cardiac repolarization and is of major concern for drug safety. The objective of the present study was to assess prolongation of cardiac repolarization during the combined use of two IKr blockers when administered sequentially in different orders.
Methods: Hearts (n=84) from Hartley male guinea-pigs were isolated and buffer-perfused in the Langendorff mode. Monophasic action potential duration was measured at 90% repolarization (MAPD90). After a 5 min perfusion with buffer, hearts were perfused with[domperidone (50, 150 and 300 nM) followed by erythromycin (10
M) or by ketoconazole (10
M)], or inversely with[ketoconazole administered first (10
M) followed by domperidone (50, 150 and 300 nM)].
Results: Increasing concentrations of domperidone caused a concentration-dependent prolongation of MAPD90. Sequential administration of erythromycin or ketoconazole caused an additive effect. In contrast, MAPD90 prolongation caused by domperidone was no longer concentration-dependent when ketoconazole was administered first.
Conclusion: Our results demonstrate that the order of the sequential administration of two IKr blockers seems to be an important factor on lengthening of cardiac repolarization. Further studies are necessary to elucidate the responsible mechanism.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
PII-8Clinical Pharmacology & Therapeutics null
PIII-79Clinical Pharmacology & Therapeutics null
CYP2J2 metabolizes domperidone in guinea pig heartsClinical Pharmacology & Therapeutics null
Distribution of 3 H-domperidone, a P-glycoprotein (P-gp) substrate, in heart structures and whole-body tissues of MDR1A (−/−) miceClinical Pharmacology & Therapeutics null
See all 6 matches for Research